News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientist Recognised with Cancer Charity’s Highest Honour
The ICR's Professor Mel Greaves has become the first scientist honoured with leading blood cancer charity Leukaemia & Lymphoma Research's highest award.
Topping out ceremony marks milestone for The Royal Marsden and the ICR
Progress on The Royal Marsden and the ICR's new Centre for Molecular Pathology in Sutton, Surrey, has reached a major milestone with a topping out ceremony this week.
Global Award for Prostate Cancer Blood Test Developer
A scientist from the ICR and The Royal Marsden, Dr Timothy Yap, has received an award for ongoing work developing a blood test to predict how prostate cancer patients will respond to treatment.
First Risk Genes Found for Bone Marrow Cancer
A team of scientists led by the ICR has shown for the first time that a person’s genes influences their risk of developing multiple myeloma, according to a paper publishing in the journal Nature Genetics.
First patients enrolled in personalised medicine project
Clinicians and scientists at The Royal Marsden and the ICR are taking part in a ground-breaking national project which could lead to personalised cancer treatment for individual patients.
Gene Profiling Has Improved - But Not Yet Personalised - Breast Cancer Treatment
Genetic profiling has revolutionised our understanding of breast cancer, but more work is needed before we can deliver truly personalised medicine to patients, Professor Jorge Reis-Filho from the ICR writes in the prestigious journal The Lancet.
ICR Scientists at Forefront of High-Tech Gene Sequencing Initiative
Three new projects will use the latest sequencing machines to unravel the genetic secrets behind a range of cancers.
Skin Cancer Drug Development Boosted with £3m Grant
The ICR and The Royal Marsden are to progress into patient trials an experimental drug to combat the most deadly form of skin cancer. The BRAF-inhibitor has the potential to treat more sub-types of malignant melanoma than any other targeted treatments for this cancer.
ICR drug discovery highlighted for patient impact
Drug discovery research by ICR scientists has been singled out by a leading cancer journal for the current and future impact it is having on patients, and will be the subject of a presentation at an international cancer conference.
Positive Survival Data from Interim Analysis of Phase III Trial of Prostate Cancer Drug
A new type of hormonal treatment has been shown to extend life for men with advanced prostate cancer, according to an interim analysis of a Phase III trial jointly led by Professor Johann de Bono from the ICR and The Royal Marsden Hospital.
Young ICR scientists win European research award
Two up-and-coming ICR scientists have taken first and third prize in a Europe-wide cancer research competition.
National Cancer Research Institute (NCRI) Cancer Conference 2011
The NCRI Cancer Conference is the UK’s major forum for showcasing the best British and international cancer research.
